Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 5

The effects of vitamin D supplemantation on prognosis in patients with mild obstructive sleep apnea syndrome

Pages
2524–2533
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: As a result, it is thought that vitamin D supplementation may have a positive effect on the disease prognosis of mild OSAS.Key words: Vitamin D supplementation, obstructive sleep apnea, biochemical parameters, inflammation

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: The aim of this study was to investigate the effect of vitamin D on the disease prognosis and biochemical parameters in patients with mild obstructive sleep apnea syndrome (OSAS).
📊
Key Findings & Data:Materials and methods: Nineteen adult male individuals (18–65 years) who were diagnosed with mild OSAS after polysomnography and had low vitamin D levels were included in the study.
💡
Conclusion & Impact:Conclusion: As a result, it is thought that vitamin D supplementation may have a positive effect on the disease prognosis of mild OSAS.Key words: Vitamin D supplementation, obstructive sleep apnea, biochemical parameters, inflammation
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: The aim of this study was to investigate the effect of vitamin D on the disease prognosis and biochemical parameters in patients with mild obstructive sleep apnea syndrome (OSAS). Materials and methods: Nineteen adult male individuals (18–65 years) who were diagnosed with mild OSAS after polysomnography and had low vitamin D levels were included in the study. Each week, patients took 50.000 IU Vitamin D3 supplementation for 8 weeks. Polysomnography, biochemical parameters FBG (fasting blood glucose), lipid profile (TG, TC, LDL-C, HDL-C, VLDL-C), calcium, phosphorus, parathormone, calcitonin, serum 25(OH)D, insulin, CRP, TNF-α, IL-6, and IL-10 of patients were evaluated at the beginning of study and at the end of the study. All assessments, including polysomnography, were repeated after 8 weeks. Results: Serum vitamin D levels were initially 19.5 ± 5.01 ng/mL and increased to 41.8 ± 10.51 ng/mL (p < 0.001) at the end of the study. FBG, TC and HOMA-IR of the patients were significantly decreased (p < 0.05). CRP, TNF-α, IL-6, and IL-10 levels were also correlated with serum vitamin D levels (p < 0.05). There was a significant decrease in number of obstructive apneas, apneas and hypopneas, apnea index, hypopnea index, and apnea hypopnea index of the patients (p < 0.05). Conclusion: As a result, it is thought that vitamin D supplementation may have a positive effect on the disease prognosis of mild OSAS.Key words: Vitamin D supplementation, obstructive sleep apnea, biochemical parameters, inflammation

🔖

Cite This Article

GÜLBAHAR, Ö., AFANDIYEVA, N., AYYILDIZ, F., YILDIRAN, H., KÖKTÜRK, O. (2022). The effects of vitamin D supplemantation on prognosis in patients with mild obstructive sleep apnea syndrome. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 5, 2524–2533. https://ajindex.com/articles/609562

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Hong S, Chen YF, Jung Y, Kwon YD, Liu SYC. Hypoglossal nerve stimulation for treatment of obstructive sleep apnea (OSA): a primer for oral and maxillofacial surgeons. Maxillofacial Plastic and Reconstructive Surgery 2017
  2. doi: 10.1186/s40902-017-0126-0 2. Epstein LJ, Kristo D, Strollo PJ, Friedman N, Malhotra A et al. Clinical guideline for the evaluation, management and longterm care of obstructive sleep apnea in adults. Journal of Clinical Sleep Medicine 2009
  3. 5 (3): 263-276. 3. Cowie MR. Sleep apnea: state of the art. Trends in Cardiovascular Medicine 2017
  4. 27 (4): 280-289. doi: 10.1016/j.tcm.2016.12.005 4. Neighbors CL, Noller MW, Song SA, Zaghi S, Neighbors J et al. Vitamin D and obstructive sleep apnea: a systematic review and meta-analysis. Sleep Medicine 2017
  5. 43 (1): 100-108. doi: 10.1016/j.sleep.2017.10.016 5. Köktürk O, Ulukavak Çiftçi T, Mollarecep E, Çiftçi B. Elevated Creactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. International Heart Journal 2005
  6. doi: 10.1536/ihj.46.801 6. Alberti A, Sarchielli P, Gallinella E, Floridi A, Floridi A et al. Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study. Journal of Sleep Research 2003
  7. 12 (4): 305-311. doi: 10.1111/j.1365- 2869.2003.00361.x 7. Sniderman AD, Cianflone K. Substrate delivery as a determinant of hepatic apoB secretion. Arteriosclerosis, Thrombosis, and Vascular Biology 1993
  8. 13 (5): 629-636. doi: 10.1161/01.atv.13.5.629 8. Köktürk O, Kanbay A. Insulin resistance in patients with obstructive sleep apnea syndrome. Eurasian Journal of Pulmonology 2003
  9. 15 (2): 135-136. doi: 10.5152/solunum.2013.027 9. Kushida CA, Morgenthaler TI, Littner MR, Alessi CA, Bailey D et al. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances: an update for 2005. Sleep 2006
  10. 29 (2): 240-243. doi: 10.1093/sleep/29.2.240 10. Demir A, Ursavaş A, Tana Aslan A, Gülbay B, Çiftçi B et al. Türk Toraks Derneği Obstrüktif Uyku Apne Sendromu Tanı ve Tedavi Uzlaşı Raporu. Türk Toraks Dergisi 2012
  11. 13 (Suppl 1): 1-73 (in Turkish). 11. Huang YC, Lin CY, Lan CC, Wu YK, Lim CS et al. Comparison of cardiovascular co-morbidities and CPAP use in patients with positional and non-positional mild obstructive sleep apnea. BMC Pulmonary Medicine 2014
  12. 14 (1): 140-153. doi: 10.1186/1471-2466-14-153 12. Budhiraja R, Budhiraja P, Quan SF. Sleep-disordered breathing and card